Monkeypox: A zoonosis of global concern

Authors

  • Ana Carolina Leal da Cruz Lisboa Universidade de Marília
  • Bruna Crescenti Tukasan Universidade de Marília
  • Caio Ferreira Repik Universidade de Marília
  • Raul José Silva Girio Universidade de Marília

DOI:

https://doi.org/10.31533/pubvet.v16n11a1255.1-7

Keywords:

Monkeypox, monkeypox virus, public health, zoonosis

Abstract

Monkeypox is a zoonotic disease from Africa, caused by the monkeypox virus (MPXV), belonging to the Poxviridae family. Initially discovered in 1958, the 2022 outbreak comprises the disease in its largest worldwide distribution since then. The virus enters the organism from the respiratory tract and its transmission can occur by direct contact with infected animal or human hosts. The present article elucidates the MPXV history from an epidemiological point of view, contemplating the origin of the etiologic agent, its transmission mechanisms, pathophysiology, symptomatology, diagnostic tools, treatment, means of control and prevention, as well as the chronology of reported cases of MPXV up until the current epidemic.

References

Ajmera, K. M., Goyal, L., Pandit, T., & Pandit, R. (2022). Monkeypox–An emerging pandemic. IDCases, 29, e01587. https://doi.org/10.1016/j.idcr.2022.e01587.

Alakunle, E., Moens, U., Nchinda, G., & Okeke, M. I. (2020). Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses, 12(11), 1257. https://doi.org/10.3390/v12111257.

Antinori, A., Mazzotta, V., Vita, S., Carletti, F., Tacconi, D., Lapini, L. E., D’Abramo, A., Cicalini, S., Lapa, D., & Pittalis, S. (2022). Group tIM Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Sutveillance, 27(2). https://doi.org/10.2807/1560-7917.ES.2022.27.22.2200421.

ANVISA (2022). Agência Nacional de Vigilância Sanitária. Nota técnica GVIMS/GGTES/DIRE3/ANVISA Nº 03/2022 - Orientações para Prevenção e Controle da Monkeypox nos Serviços de Saúde. Brasília, 1-34, 2022. Disponível em: https://www.gov.br/anvisa/pt-br. Acesso em: 06 ago. 2022.

Bigaran, L. T., Barbosa, T. C., Barrachi, B. M., Fuza, P. F. N. S., Alssuffi, J. E. A., Alssuffi, M. E. A., Orta, B. H. S., Macedo, V. C., Marinelli, F. P., & Lima, R. E. A. (2022). Uma revisão de literatura sobre os aspectos clínicos e epidemiológicos da Monkeypox. Research, Society and Development, 11(9), e23411931612–e23411931612.

BRASIL (2022). Ministério da Saúde. Boletim epidemiológico especial: Monkeypox, Brasília, n.6, mai./jul. 2022. Disponível em: https://www.gov.br/saude/pt-br. Acesso em: 22 jul. 2022.

Brown, K., & Leggat, P. A. (2016). Human monkeypox: current state of knowledge and implications for the future. Tropical Medicine and Infectious Disease, 1(1), 8. https://doi.org/10.3390/tropicalmed1010008.

Bunge, E. M., Hoet, B., Chen, L., Lienert, F., Weidenthaler, H., Baer, L. R., & Steffen, R. (2022). The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS Neglected Tropical Diseases, 16(2), e0010141. https://doi.org/10.1371/ journal.pntd.0010141.

Centers For Disease Control. (2022). Monkeypox in animals. Disponível em: https://www.cdc.gov/poxvirus/monkeypox. Acesso em: 27 jul. 2022.

Claro, I. M., Romano, C. M., Candido, D. S., Lima, E. L., Lindoso, J. A. L., Ramundo, M. S., Moreira, F. R. R., Barra, L. A. C., Borges, L. M. S., & Medeiros, L. A. (2022). Shotgun metagenomic sequencing of the first case of monkeypox virus in Brazil, 2022. Revista Do Instituto de Medicina Tropical de São Paulo, 64, e48. https://doi.org/10.1590/S1678-9946202264048.

Di Giulio, D. B., & Eckburg, P. B. (2004). Human monkeypox: an emerging zoonosis. The Lancet Infectious Diseases, 4(1), 15–25. https://doi.org/10.1016/s1473-3099(03)00856-9.

Erez, N., Achdout, H., Milrot, E., Schwartz, Y., Wiener-Well, Y., Paran, N., Politi, B., Tamir, H., Israely, T., & Weiss, S. (2019). Diagnosis of imported monkeypox, Israel, 2018. Emerging Infectious Diseases, 25(5), 980. https://doi.org/10.3201/eid2505.190076.

Estevam, G., & Job, J. R. P. P. (2016). Animais exóticos domesticados com potencial zoonótico-Revisão de literatura. Revista Da Sociedade Brasileira de Clínicas Médicas, 14, 114–120.

Finger-Jardim, F. (2022). Varíola dos macacos: Novo surto global. VITTALLE-Revista de Ciências Da Saúde, 34(1), 7–8.

Gong, Q., Wang, C., Chuai, X., & Chiu, S. (2022). Monkeypox virus: a re-emergent threat to humans. Virologica Sinica. https://doi.org/10.1016/j.virs.2022.07.006.

Guarner, J., Del Rio, C., & Malani, P. N. (2022). Monkeypox in 2022—what clinicians need to know. Jama, 328(2), 139–140. https://doi.org/10.1001/jama.2022.10802.

Isidro, J., Borges, V., Pinto, M., Sobral, D., Santos, J. D., Nunes, A., Mixão, V., Ferreira, R., Santos, D., & Duarte, S. (2022). Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus. Nature Medicine, 28(8), 1569–1572. https://doi.org/10.1038/s41591-022-01907-y.

Kraemer, M. U. G., Tegally, H., Pigott, D. M., Dasgupta, A., Sheldon, J., Wilkinson, E., Schultheiss, M., Han, A., Oglia, M., & Marks, S. (2022). Tracking the 2022 monkeypox outbreak with epidemiological data in real-time. The Lancet Infectious Diseases. https://doi.org/10.1016/S1473-3099(22)00359-0.

Kumar, N., Acharya, A., Gendelman, H. E., & Byrareddy, S. N. (2022). The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of Autoimmunity, 102855. https://doi.org/10.1016/j.jaut.2022.102855.

McCollum, A. M., & Damon, I. K. (2014). Human monkeypox. Clinical Infectious Diseases, 58(2), 260–267. https://doi.org/10.14295/bjs.v1i10.179.

Menezes Filho, A. C. P., Ventura, M. V. A., Alves, I., & Taques, A. S. (2022). Monkeypox: World health emergency in 2022. Brazilian Journal of Science, 1(10), 5–11.

Moore, M. J., Rathish, B., & Zahra, F. (2022). Monkeypox. In StatPearls (pp. 1–15).

Petersen, E. (2019). Human Monkeypox. Infectious Disease Clinics of North America, 33(4), 1027–1043. https://doi.org/10.1016/j.idc.2019.03.0.

São Paulo (2022). Governo de São Paulo. Alerta Epidemiológico - Número 8/2022 – 22/07/2022 Monkeypox - MPX. Central/Cievs - Centro de Informações Estratégicas em Vigilância em Saúde - Instituto Adolfo Lutz, São Paulo, p. 1-18, jul. 2022.

Seang, S., Burrel, S., Todesco, E., Leducq, V., Monsel, G., Le Pluart, D., Cordevant, C., Pourcher, V., & Palich, R. (2022). Evidence of human-to-dog transmission of monkeypox virus. The Lancet, 400(10353), 658–659. https://doi.org/10.1016/S0140-6736(22)01487-8.

Sklenovska, N., & Van Ranst, M. (2018). Emergence of monkeypox as the most important orthopoxvirus infection in humans. Frontiers in Public Health, 6, 241. https://doi.org/10.3389/fpubh.2018.00241.

Thakur, V., Thakur, P., Srivastava, S., & Kumar, P. (2022). Monkeypox virus (MPX) in humans a concern: Trespassing the global boundaries–Correspondence. International Journal of Surgery, 104, 106703. https://doi.org/10.1016/j.ijsu.2022.106703.

Thornhill, J. P., Barkati, S., Walmsley, S., Rockstroh, J., Antinori, A., Harrison, L. B., Palich, R., Nori, A., Reeves, I., & Habibi, M. S. (2022). Monkeypox virus infection in humans across 16 countries—April–June 2022. New England Journal of Medicine, 387(8), 679–691. https://doi.org/10.1056/NEJMoa2207323.

Velavan, T. P., & Meyer, C. G. (2022). Monkeypox 2022 outbreak: an update. Tropical Medicine & International Health, 27(7), 604–605. https://doi.org/10.1111/tmi.13785.

Wang, L. F., & Crameri, G. (2014). Emerging zoonotic viral diseases. Revue Scientifique et Technique, 33(2), 569–581. https://doi.org/10.20506/rst.33.2.2311.

WHO (2022). World health organization. Clinical Management and Infection Prevention and Control for Monkeypox: interim rapid response guidance, p 1-76, jun, 2022.

WHO (2022). World health organization. Multi-country outbreak of monkeypox, External situation report #6 - 21 September 2022. Disponível em: https://www.who.int/publications/. Acesso em: 1 out. 2022.

WHO (2022). World Heath Organization. Notícias. Monkeypox. Disponível em: https://www.who.int/news-room/fact-sheets/detail/monkeyxternal-situation-report--3---10-august-202pox. Acesso em: 11 jul. 2022.

Yang, G., Pevear, D. C., Davies, M. H., Collett, M. S., Bailey, T., Rippen, S., Barone, L., Burns, C., Rhodes, G., & Tohan, S. (2005). An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge. Journal of Virology, 79(20), 13139–13149. https://doi.org/10.1128/JVI.79.20.13139-13149.2005.

Published

2022-11-16

Issue

Section

Saúde pública

Most read articles by the same author(s)